In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hemocane Drug Master File in Korea (Hemocane KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hemocane. The MFDS reviews the Hemocane KDMF as part of the drug registration process and uses the information provided in the Hemocane KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hemocane KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hemocane API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hemocane suppliers with KDMF on PharmaCompass.